"Balance, Gait, and Motion Analysis in Multiple Sclerosis"

NCT07630311 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2026-06-24

No results posted yet for this study

Summary

The goal of this observational cross-sectional study is to investigate the relationship between functional measures of balance and gait and objective kinetic and kinematic parameters in people with Multiple Sclerosis (MS).

The main questions it aims to answer are:

i) What is the relationship between kinetic and kinematic gait and balance parameters measured using the Vicon motion analysis system and performance on clinical functional assessments in people with Multiple Sclerosis?

ii) Which biomechanical parameters are most strongly associated with functional balance, gait, and physical performance outcomes?

Participants will attend a single laboratory-based assessment session. During this session, they will undergo biomechanical gait and balance analysis using the Vicon motion capture system, complete functional assessments of balance, gait, and physical performance, complete questionnaires assessing fear of falling and fatigue, and undergo assessment of lower-limb spasticity.

Conditions

  • Multiple Sclerosis
  • Gait Disorders, Neurologic
  • Postural Balance
  • Motion Analysis
  • Biomechanics
  • Kinetics
  • Kinematics
  • Physiotherapy
  • Fatigue
  • Fall

Sponsors & Collaborators

  • University Hospital, Ioannina

    collaborator OTHER
  • University of Patras

    lead OTHER

Principal Investigators

  • Sofia Lampropoulou, PT, MSc, PhD · Department of Physiotherapy, University of Patras

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-09-01
Primary Completion
2026-02-28
Completion
2026-08-30

Countries

  • Greece

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07630311 on ClinicalTrials.gov